http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011059554-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81c61367bd056d7ad775949d75870b2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f6f18f88f4933971992e311d594419a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f51d107a77a4a18757ee03c6ad04c7ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_49d77917ee653bd2583a814a75ef54b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_715d63125b7be146c370029a6192040b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a84e00934da46e36b99f65bfc947ca3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6848
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6851
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
filingDate 2010-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fa9ef8f7f706c4d0be1bc32dcadecec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fcb613b7d6d81ea68f8afe56420eae3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b53b81aec26a03013209eb72b86e5bb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd3d9dc940d8310e1a9819499f436cab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db6fd3a98bdbb51fe0f3662167fffc17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0fed4e1c7c78faf821e39f9b71df9a8
publicationDate 2011-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2011059554-A1
titleOfInvention Determining an expression status of human epidermal growth factor receptor 2 (her2) in a biological sample
abstract A method for determining an expression of human epidermal growth factor receptor 2 (HER2) of a subject. The method includes providing a sample from the subject; measuring one of (i) amounts of two or more proteins in the sample, each protein having a molecular weight substantially equal to 4740, 8404, 8419, 8435, 8450, 8455, 8465, 8570, 8607 or 8626 atomic mass units, and (ii) amounts of at least one of human cystein-rich intestinal protein 1 (CRIP1), one or more variants of the human cystein-rich intestinal protein 1 (CRIP1 variants), and proteolytic digestion products thereof in the sample; and comparing the amounts of the proteins to control amounts, which control amounts are determinative of the expression of the human epidermal growth factor receptor 2.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11270876-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10916415-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11367606-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10777398-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11264223-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106018813-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11454611-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11031222-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11367605-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10978284-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10777397-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3570315-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11133164-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105353126-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11239066-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11289320-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11031223-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11139156-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11342170-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11282688-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11037774-B2
priorityDate 2009-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008176258-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7452727-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7811778-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6331297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394204
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6042
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423136
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128350882
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3032583
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128896208
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID320930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400876
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400875
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396147
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID637775

Total number of triples: 72.